Results 121 to 130 of about 279,790 (190)

Cutaneous adverse events following CAR T-cell therapy in hematologic malignancies. [PDF]

open access: yesBlood Cancer J
Umyarova E   +8 more
europepmc   +1 more source

CAR T cell therapy in autoantibody-mediated neurological disorders: a promising strategy. [PDF]

open access: yesJ Neuroinflammation
Wen M   +10 more
europepmc   +1 more source

Obstacles and improvement strategies for CAR-T cell therapy in solid tumors. [PDF]

open access: yesDiscov Oncol
Luo Z   +9 more
europepmc   +1 more source

Editorial: Enhancing CAR T-cell therapy with imaging. [PDF]

open access: yesFront Immunol
Lopci E, de Jong D, Dercle L.
europepmc   +1 more source

Nanoparticles-enhanced CAR-T cell therapy: current advances and future directions. [PDF]

open access: yesBiomark Res
Wang Z   +14 more
europepmc   +1 more source

AL amyloidosis: a real-world experience with CAR T-cell therapy. [PDF]

open access: yesBlood Adv
Tan MSY   +23 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy